Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase

Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Inhibitor-2 (I-2) is the regulatory subunit of a cytosolic type 1 Ser/Thr protein phosphatase (PP1) and potently inhibits the activity of the free catalytic subunit (CS1). Previous work from the laboratory had proposed that the interaction of I-2 with CS1 involved multiple sites (Park, I. K., and DePaoli-Roach, A. A. (1994) J. Biol. Chem. 269, 28919-28928). The present study refines the earlier analysis and arrives at a more detailed model for the interaction between I-2 and CS1. Although the NH2-terminal I-2 regions containing residues 1-35 and 1-64 have no inhibitory activity on their own, they increase the IC50 for I-2 by ~30-fold, indicating the presence of a CS1-interacting site. Based on several experimental approaches, we have also identified the sequence Lys144-Leu-His-Tyr147 as a second site of interaction that corresponds to the RVXF motif present in many CS1-binding proteins. The peptide I-2(135-151) significantly increases the IC50 for I-2 and attenuates CS1 inhibition. Replacement of Leu and Tyr with Ala abolishes the ability to counteract inhibition by I-2. The I-2(135-151) peptide, but not I-2(1-35), also antagonizes inhibition of CS1 by DARPP-32 in a pattern similar to that of I-2. Furthermore, a peptide derived from the glycogen-binding subunit, R(GL)/G(M)(61-80), which contains a consensus CS1-binding motif, completely counteracts CS1 inhibition by I-2 and DARPP-32. The NH2-terminal 35 residues of I-2 bind to CS1 at a site that is specific for I-2, whereas the KLHY sequence interacts with CS1 at a site shared with other interacting proteins. Other results suggest the presence of yet more sites of interaction. A model is presented in which multiple 'anchoring interactions' serve to position a segment of I-2 such that it sterically occludes the catalytic pocket but need not make high affinity contacts itself.

Original languageEnglish
Pages (from-to)22635-22644
Number of pages10
JournalJournal of Biological Chemistry
Volume275
Issue number30
DOIs
StatePublished - Jul 28 2000

Fingerprint

Protein Phosphatase 1
Protein Binding
Inhibitory Concentration 50
Peptides
Phosphoprotein Phosphatases
Glycogen
Catalytic Domain
Carrier Proteins
Proteins
peptide I

ASJC Scopus subject areas

  • Biochemistry

Cite this

@article{9891faa222264c59aedbb90e537ac4d6,
title = "Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase: Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif",
abstract = "Inhibitor-2 (I-2) is the regulatory subunit of a cytosolic type 1 Ser/Thr protein phosphatase (PP1) and potently inhibits the activity of the free catalytic subunit (CS1). Previous work from the laboratory had proposed that the interaction of I-2 with CS1 involved multiple sites (Park, I. K., and DePaoli-Roach, A. A. (1994) J. Biol. Chem. 269, 28919-28928). The present study refines the earlier analysis and arrives at a more detailed model for the interaction between I-2 and CS1. Although the NH2-terminal I-2 regions containing residues 1-35 and 1-64 have no inhibitory activity on their own, they increase the IC50 for I-2 by ~30-fold, indicating the presence of a CS1-interacting site. Based on several experimental approaches, we have also identified the sequence Lys144-Leu-His-Tyr147 as a second site of interaction that corresponds to the RVXF motif present in many CS1-binding proteins. The peptide I-2(135-151) significantly increases the IC50 for I-2 and attenuates CS1 inhibition. Replacement of Leu and Tyr with Ala abolishes the ability to counteract inhibition by I-2. The I-2(135-151) peptide, but not I-2(1-35), also antagonizes inhibition of CS1 by DARPP-32 in a pattern similar to that of I-2. Furthermore, a peptide derived from the glycogen-binding subunit, R(GL)/G(M)(61-80), which contains a consensus CS1-binding motif, completely counteracts CS1 inhibition by I-2 and DARPP-32. The NH2-terminal 35 residues of I-2 bind to CS1 at a site that is specific for I-2, whereas the KLHY sequence interacts with CS1 at a site shared with other interacting proteins. Other results suggest the presence of yet more sites of interaction. A model is presented in which multiple 'anchoring interactions' serve to position a segment of I-2 such that it sterically occludes the catalytic pocket but need not make high affinity contacts itself.",
author = "J. Yang and Thomas Hurley and {De Paoli-Roach}, Anna",
year = "2000",
month = "7",
day = "28",
doi = "10.1074/jbc.M003082200",
language = "English",
volume = "275",
pages = "22635--22644",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "30",

}

TY - JOUR

T1 - Interaction of inhibitor-2 with the catalytic subunit of type 1 protein phosphatase

T2 - Identification of a sequence analogous to the consensus type 1 protein phosphatase-binding motif

AU - Yang, J.

AU - Hurley, Thomas

AU - De Paoli-Roach, Anna

PY - 2000/7/28

Y1 - 2000/7/28

N2 - Inhibitor-2 (I-2) is the regulatory subunit of a cytosolic type 1 Ser/Thr protein phosphatase (PP1) and potently inhibits the activity of the free catalytic subunit (CS1). Previous work from the laboratory had proposed that the interaction of I-2 with CS1 involved multiple sites (Park, I. K., and DePaoli-Roach, A. A. (1994) J. Biol. Chem. 269, 28919-28928). The present study refines the earlier analysis and arrives at a more detailed model for the interaction between I-2 and CS1. Although the NH2-terminal I-2 regions containing residues 1-35 and 1-64 have no inhibitory activity on their own, they increase the IC50 for I-2 by ~30-fold, indicating the presence of a CS1-interacting site. Based on several experimental approaches, we have also identified the sequence Lys144-Leu-His-Tyr147 as a second site of interaction that corresponds to the RVXF motif present in many CS1-binding proteins. The peptide I-2(135-151) significantly increases the IC50 for I-2 and attenuates CS1 inhibition. Replacement of Leu and Tyr with Ala abolishes the ability to counteract inhibition by I-2. The I-2(135-151) peptide, but not I-2(1-35), also antagonizes inhibition of CS1 by DARPP-32 in a pattern similar to that of I-2. Furthermore, a peptide derived from the glycogen-binding subunit, R(GL)/G(M)(61-80), which contains a consensus CS1-binding motif, completely counteracts CS1 inhibition by I-2 and DARPP-32. The NH2-terminal 35 residues of I-2 bind to CS1 at a site that is specific for I-2, whereas the KLHY sequence interacts with CS1 at a site shared with other interacting proteins. Other results suggest the presence of yet more sites of interaction. A model is presented in which multiple 'anchoring interactions' serve to position a segment of I-2 such that it sterically occludes the catalytic pocket but need not make high affinity contacts itself.

AB - Inhibitor-2 (I-2) is the regulatory subunit of a cytosolic type 1 Ser/Thr protein phosphatase (PP1) and potently inhibits the activity of the free catalytic subunit (CS1). Previous work from the laboratory had proposed that the interaction of I-2 with CS1 involved multiple sites (Park, I. K., and DePaoli-Roach, A. A. (1994) J. Biol. Chem. 269, 28919-28928). The present study refines the earlier analysis and arrives at a more detailed model for the interaction between I-2 and CS1. Although the NH2-terminal I-2 regions containing residues 1-35 and 1-64 have no inhibitory activity on their own, they increase the IC50 for I-2 by ~30-fold, indicating the presence of a CS1-interacting site. Based on several experimental approaches, we have also identified the sequence Lys144-Leu-His-Tyr147 as a second site of interaction that corresponds to the RVXF motif present in many CS1-binding proteins. The peptide I-2(135-151) significantly increases the IC50 for I-2 and attenuates CS1 inhibition. Replacement of Leu and Tyr with Ala abolishes the ability to counteract inhibition by I-2. The I-2(135-151) peptide, but not I-2(1-35), also antagonizes inhibition of CS1 by DARPP-32 in a pattern similar to that of I-2. Furthermore, a peptide derived from the glycogen-binding subunit, R(GL)/G(M)(61-80), which contains a consensus CS1-binding motif, completely counteracts CS1 inhibition by I-2 and DARPP-32. The NH2-terminal 35 residues of I-2 bind to CS1 at a site that is specific for I-2, whereas the KLHY sequence interacts with CS1 at a site shared with other interacting proteins. Other results suggest the presence of yet more sites of interaction. A model is presented in which multiple 'anchoring interactions' serve to position a segment of I-2 such that it sterically occludes the catalytic pocket but need not make high affinity contacts itself.

UR - http://www.scopus.com/inward/record.url?scp=0034725628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034725628&partnerID=8YFLogxK

U2 - 10.1074/jbc.M003082200

DO - 10.1074/jbc.M003082200

M3 - Article

VL - 275

SP - 22635

EP - 22644

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 30

ER -